Related references
Note: Only part of the references are listed.Antitumor effects of the benzophenanthridine alkaloid sanguinarine: Evidence and perspectives
Roberta Gaziano et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells
Dae-Woon Eom et al.
BMB REPORTS (2015)
Oral Cavity Cancer: Risk Factors, Pathology, and Management
Vinicius Ernani et al.
ONCOLOGY (2015)
Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck
Daniel R. Simpson et al.
ORAL ONCOLOGY (2015)
Plant derived substances with anti-cancer activity: from folklore to practice
Marcelo Fridlender et al.
FRONTIERS IN PLANT SCIENCE (2015)
Grape Seed Extract and Resveratrol Prevent 4-Nitroquinoline 1-Oxide Induced Oral Tumorigenesis in Mice by Modulating AMPK Activation and Associated Biological Responses
Sangeeta Shrotriya et al.
MOLECULAR CARCINOGENESIS (2015)
Postoperative Radiotherapy for Patients at High Risk of Recurrence of Oral Cavity Squamous Cell Carcinoma
Michael P. Herman et al.
LARYNGOSCOPE (2015)
Bucillamine prevents cisplatin-induced ototoxicity through induction of glutathione and antioxidant genes
Se-Jin Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Role of AMP-Activated Protein Kinase in Cancer Therapy
Gauhar Rehman et al.
ARCHIV DER PHARMAZIE (2014)
Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC
Susan Heavey et al.
CANCER TREATMENT REVIEWS (2014)
Protective effect of sanguinarine on LPS-induced endotoxic shock in mice and its effect on LPS-induced COX-2 expression and COX-2 associated PGE2 release from peritoneal macrophages
Weifeng Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Current Treatment of Head and Neck Squamous Cell Cancer
Ryan Belcher et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Targeting caspases in cancer therapeutics
Patrick Hensley et al.
BIOLOGICAL CHEMISTRY (2013)
Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas
Mark W. Lingen et al.
ORAL ONCOLOGY (2013)
Apoptosis Induction of Human Bladder Cancer Cells by Sanguinarine through Reactive Oxygen Species-Mediated Up-Regulation of Early Growth Response Gene-1
Min Ho Han et al.
PLOS ONE (2013)
Targeting the AMP-activated pro prevention and therapy
In Young Kim et al.
FRONTIERS IN ONCOLOGY (2013)
PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes
Ipsita Pal et al.
ACTA PHARMACOLOGICA SINICA (2012)
The anti-inflammatory effects of sanguinarine and its modulation of inflammatory mediators from peritoneal macrophages
Xiaofeng Niu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
In Vitro Antifungal Activity of Sanguinarine and Chelerythrine Derivatives against Phytopathogenic Fungi
Xin-Juan Yang et al.
MOLECULES (2012)
Ras oncogenes in oral cancer: The past 20 years
Avaniyapuram Kannan Murugan et al.
ORAL ONCOLOGY (2012)
AMPK functions as an adenylate charge-regulated protein kinase
Jonathan S. Oakhill et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
BH3-only proteins: Orchestrators of apoptosis
Aisha Shamas-Din et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Targeting the extrinsic apoptosis signaling pathway for cancer therapy
Thomas J. Sayers
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Targeting the AKT Pathway in Glioblastoma
Kelli A. McDowell et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Structural modification of sanguinarine and chelerythrine and their antibacterial activity
Fang Miao et al.
NATURAL PRODUCT RESEARCH (2011)
Pathological roles of MAPK signaling pathways in human diseases
Eun Kyung Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
Subash C. Gupta et al.
CANCER AND METASTASIS REVIEWS (2010)
Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells
Yung Hyun Choi et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Mitochondrial cell death effectors
Dirk Brenner et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Dysregulated molecular networks in head and neck carcinogenesis
Alfredo A. Molinolo et al.
ORAL ONCOLOGY (2009)
Signal integration by JNK and p38 MAPK pathways in cancer development
Erwin F. Wagner et al.
NATURE REVIEWS CANCER (2009)
Membrane Binding by tBid Initiates an Ordered Series of Events Culminating in Membrane Permeabilization by Bax
Jonathan F. Lovell et al.
CELL (2008)
Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation
Min Ho Han et al.
CHEMOTHERAPY (2008)
Sanguinarine, a benzophenanthridine alkaloid, induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen species-mediated mitochondrial pathway
Woo Young Choi et al.
CHEMOTHERAPY (2008)
Targeting Cell Death in Tumors by Activating Caspases
A. Clark et al.
CURRENT CANCER DRUG TARGETS (2008)
Akt as a therapeutic target in cancer
Linda S. Steelman et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
IAPs as a target for anticancer therapy
S. Danson et al.
CURRENT CANCER DRUG TARGETS (2007)
Sanguinarine inhibits VEGF-induced angiogenesis in a fibrin gel matrix
Giuseppina Basini et al.
BIOFACTORS (2007)
The role of the mitochondrial permeability transition in cell death
Jeffrey S. Armstrong
MITOCHONDRION (2006)
Plants as a source of anti-cancer agents
GM Cragg et al.
JOURNAL OF ETHNOPHARMACOLOGY (2005)
Effects of sanguinaria in fluoride-containing dentifrices on the remineralisation of subsurface carious lesion in vitro
SJ Hong et al.
INTERNATIONAL DENTAL JOURNAL (2005)
Overview of cell death signaling pathways
ZY Jin et al.
CANCER BIOLOGY & THERAPY (2005)
Suppression of angiogenesis by the plant alkaloid, sanguinarine
JP Eun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Sanguinarine is a potent inhibitor of oxidative burst in DMSO-differentiated HL-60 cells by a non-redox mechanism
J Vrba et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2004)
Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?
AO de Graaf et al.
LEUKEMIA (2004)
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal
T Tsuruo et al.
CANCER SCIENCE (2003)
Protein kinase substrate recognition studied using the recombinant catalytic domain of AMP-activated protein kinase and a model substrate
JW Scott et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Share Paper
